Mesirow Financial Investment Management, Inc.
Position in GILD — Gilead Sciences, Inc.
CIK 1469475
CHICAGO, IL
Position in GILD
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$862,270
-$81,264 QoQ
Shares Held
6,825
+0.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#1,143
of 2,266 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Mesirow Financial Investment Management, Inc. holds $112,278,631 across 12 Drug Manufacturers - General names. GILD ranks #9 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
158,995 | $40,009,501 | |
| 2 | JNJ |
Johnson & Johnson
|
115,650 | $29,371,630 | |
| 3 | LLY |
ELI LILLY & Co
|
15,088 | $18,097,001 | |
| 4 | PFE |
Pfizer Inc
|
399,667 | $9,623,981 | |
| 5 | AMGN |
Amgen Inc
|
14,518 | $5,257,258 | |
| 6 | MRK |
Merck & Co., Inc.
|
39,351 | $5,056,603 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
32,023 | $1,845,165 | |
| 8 | GSK |
GSK plc
|
17,087 | $895,700 |
All Filings in GILD
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $862,270 | 6,825 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $943,534 | 6,770 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $779,399 | 6,350 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $817,404 | 7,364 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $816,224 | 7,362 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $832,979 | 7,434 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $645,851 | 6,992 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $577,741 | 6,891 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $479,103 | 6,983 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $516,632 | 7,053 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $679,916 | 8,393 | Shares | Sole | 2024-02-13 | |
| No filing history on record for this holder in this stock. | ||||||